Porzio Life Sciences provides Aggregate Spend Regulatory Compliance software solutions for Pharmaceutical, Medical Device & Biotech companies comply with Affordable Care Act and Sunshine Act.
HomeProducts & ServicesMedia LibraryAbout UsContact UsSubscriber LoginGoToMeetingBlog

About Us


 
About Us > Recent Articles

Recent Articles


02/27/2014   FDA’s Office of Prescription Drug Promotion (OPDP) Enforcement: A Summary of 2013 Warning and Untitled Letters
Porzio Life Sciences, LLC
by Jennifer A. Romanski, J.D. and Kim C. Capone
     
12/23/2013   Getting the Deal Through: Life Sciences 2014 - United States Chapter
Life Sciences in 24 Jurisdictions Worldwide
by John Patrick Oroho and Brian P. Sharkey
     
10/23/2013  
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
08/19/2013   Say Hi To Oscar: The New Kid That May Change Health Insurance
F
orbes.com
by Scott S. Liebman
     
08/01/2013   The Ongoing Global Transformation in Life Sciences Transparency
Porzio Life Sciences, LLC
by D. Jeffrey Campbell and Brian P. Sharkey
     
07/24/2013  
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/25/2013   Here Comes The Sunshine Act — This Time, In Europe
Law360
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/10/2013   An IMDA Article on Frank Fazio’s “Are you Licensed to Sell?” Presentation
IMDA Article
by Frank Fazio 
     
09/28/2012   Licensed to Sell? Frank Fazio Quoted In Article on Medical Device Licensing Required by States
IMDA Update
by Frank Fazio 
     
08/14/2012   The Trend Towards Global Transparency: A Challenging New World for the Life Sciences Industry
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/22/2012   Pharmaceutical Sales Representatives Exempt From Overtime
Porzio Compliance Alert
by Kerri A. Wright
     
03/19/2012   Understanding the Sunshine Act: Dispersing the Clouds of Confusion
Porzio, Bromberg & Newman P.C.
by Christine N. Bradshaw and Sandra González
     
03/15/2013  
Bloomberg BNA Pharmaceutical Law & Industry Report
by D. Jeffrey Campbell and Brian P. Sharkey
     
02/29/2012   Getting the Deal Through: Life Sciences 2012 - United States Chapter
Life Sciences in 25 Jurisdictions Worldwide
by John Patrick Oroho, Kenneth R. Meyer, and Brian P. Sharkey
     
02/13/2012   Are Pharma Sales Reps Entitled to Overtime Pay?
New Jersey Law Journal
by Kerri A. Wright
     
12/19/2011   CMS Publishes Draft Regulations to Implement the Sunshine Act
Porzio Compliance Alert
by Christine N. Bradshaw
     
05/01/2010   Taking Stock of the Marketing Retrictions and Prohibitions of Academic Medical Centers
FDLI Update
by D. Jeffrey Campbell and Christine N. Bradshaw
     
04/01/2010   Thriving Through Turmoil: Managing Sales and Marketing Regulation of the Medical Device Industry
FDLI Update
by D. Jeffrey Campbell and Jennifer A. Sanfilippo
     
02/01/2010   The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives
FDLI Update
by D. Jeffrey Campbell and Sarina D. Rivera
     
09/01/2009   Navigating Loss Reporting: How to Meet FDA and State Reporting Requirements
Thought Leadership Sales and Marketing Compliance
by Anne E. Wagstaff, John E. Niznik and Rhonda Sobral O'Toole
     
09/01/2009   What's All the Commotion Over Aggregate Spend?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Christine N. Bradshaw
     
06/01/2009   Court Prescribes No Overtime for Pharmaceutical Sales Rep
New Jersey Defense Quarterly
by Kerri A. Wright
     
05/28/2009   Sales Rep Nightmares: Emerging Issues in Marketing Compliance
FDLI Update
by John Patrick Oroho and Christine N. Bradshaw
     
03/09/2009   Over-the-Counter and Prescription Drug Manufacturers are Granted a One Year Reprieve from the Burdensome Requirements of the Consumer Product Safety Improvement Act
Porzio Pharmaceutical Alert
by Frank Fazio and Anne E. Wagstaff
     
02/01/2009   The End or Just the Beginning? Exploring Federal Preemption of State and Distribution Laws
Pharmaceutical Commerce
by Sarina D. Rivera, Jennifer A. Sanfilippo and Kiaema R. Reid
     
09/11/2009   DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Jennifer A. Romanski and Sarina D. Rivera
     
08/27/2008   Navigating Through the Disparities of State Marketing Tracking and Disclosure Laws
Thought Leadership Sales and Marketing Compliance
by Garineh S. Dovletian and Christopher R. Corallo
     
06/18/2007   Newly Enacted Nevada Statute Requires Adoption of a "Marketing Code of Conduct."
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Christopher R. Corallo and John Patrick Oroho
     
06/01/2007   State Marketing Disclosure Laws - The Unintended Consequences
FDLI Update
by Sarina D. Rivera
     
05/30/2007   Online DTC: Marketing Push Meets Consumer Pull
Pharmaceutical Commerce
by John Patrick Oroho
     
05/21/2007   Can Prosecutors Use Data from Sample Distribution as Evidence of Off-Label Promotion?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Scott S. Liebman


 
  << Back